Bristol, Liverpool, Oxford are part of a major new international project to improve our understanding of severe coronavirus infection in humans

Russell Group universities are part of a major new international project, funded by the US Food and Drug Administration (FDA) to improve our understanding of severe coronavirus infection in humans. The three-year project will bring together collaborators from the University of Liverpool, Public Health England, the University of Bristol (Dr David Matthews and Dr Andrew Davidson), the University of Oxford, A*STAR in Singapore, and King Fahd Medical City in Saudi Arabia.

The study will aim to create profiles of various coronaviruses, including SARS-CoV-2 which causes Covid-19, to inform the development of treatments and vaccines. The study will also examine newly developed technologies such as organ-on-chips to rapidly characterise coronaviruses/novel diseases and medical countermeasures.

This international collaboration builds on existing expertise in Russell Group universities while contributing to the global fight against Covid-19. 

Read more: Bristol part of new £4 million FDA study to advance understanding of severe coronavirus infection

Related case studies

Community policing in Los Angeles via the University of Leeds

The research expertise of a University of Leeds academic has helped to advise and inform new approaches to community policing within the second largest city in the US.

Read more >

University of Exeter – using AI to assess climate risk

The Joint Centre for Excellence in Environmental Intelligence (JCEEI) utilises AI to address climate and biodiversity change by interrogating multiple sources of data. It is working with a city council on how to make buildings safe during heatwaves, and collaborating with The Alan Turing Institute, energy futures lab at Imperial College London and the Universities of Edinburgh and Warwick on decision-making approaches for energy security and net zero.

Read more >